TapewireFind a company

person · Reporting owner

Stakias G. Michael

Disclosed activity across 1 company

Tapewire entity
42021
SEC CIK
0001652688

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Dorman Products, Inc.DORM · Entity 4084DirectorJune 01, 2026June 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Dorman Products, Inc.

Report date June 01, 2026 · Filed June 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect16,150 Reported balance After 2026-06-01 transaction · row 1
1 source row

Row 1 · 2026-06-01 · Grant · Acquired 1,344 · Balance 16,150

F1: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

Filing footnotes · ownership attribution and instrument terms

F1: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 01, 2026 Filed Jun 3, 2026 21:19 UTC Dorman Products, Inc. DORM · Entity 4084 GrantCommon Stock 1,344 $122.71 $164,922.24
Disclosure

SEC source: 0001628280-26-040511 · wk-form4_1780521575.xml · nonDerivative · entry 1

Stakias G. Michael · CIK 0001652688 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,150

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:11 UTC Dorman Products, Inc. DORM · Entity 4084 GrantCommon Stock 1,070 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-029316 · wk-form4_1749067719.xml · nonDerivative · entry 1

Stakias G. Michael · CIK 0001652688 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,806

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 16:09 UTC Dorman Products, Inc. DORM · Entity 4084 GrantCommon Stock 1,471 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-026498 · wk-form4_1717517342.xml · nonDerivative · entry 1

Stakias G. Michael · CIK 0001652688 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,736

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

Read SEC document
November 01, 2023 Filed Nov 3, 2023 12:40 UTC Dorman Products, Inc. DORM · Entity 4084 PurchaseCommon Stock 1,000 $65.78 $65,780.00
Disclosure

SEC source: 0001209191-23-054285 · doc4.xml · nonDerivative · entry 1

Stakias G. Michael · CIK 0001652688 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,265

Read SEC document
June 01, 2023 Filed Jun 2, 2023 18:49 UTC Dorman Products, Inc. DORM · Entity 4084 GrantCommon Stock 1,510 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-033612 · doc4.xml · nonDerivative · entry 1

Stakias G. Michael · CIK 0001652688 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,265

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

Read SEC document
June 01, 2022 Filed Jun 2, 2022 18:32 UTC Dorman Products, Inc. DORM · Entity 4084 GrantCommon Stock 1,223 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-033438 · doc4.xml · nonDerivative · entry 1

Stakias G. Michael · CIK 0001652688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,755

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

Read SEC document
June 01, 2021 Filed Jun 3, 2021 13:51 UTC Dorman Products, Inc. DORM · Entity 4084 GrantCommon Stock 1,064 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-037509 · doc4.xml · nonDerivative · entry 1

Stakias G. Michael · CIK 0001652688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,532

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 12:26 UTC Dorman Products, Inc. DORM · Entity 4084 GrantCommon Stock 1,429 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-033807 · doc4.xml · nonDerivative · entry 1

Stakias G. Michael · CIK 0001652688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,468

F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.

Read SEC document
July 02, 2019 Filed Jul 3, 2019 17:16 UTC Dorman Products, Inc. DORM · Entity 4084 GrantCommon Stock 1,158 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-040754 · doc4.xml · nonDerivative · entry 1

Stakias G. Michael · CIK 0001652688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,039

Read SEC document
July 01, 2018 Filed Jul 2, 2018 21:31 UTC Dorman Products, Inc. DORM · Entity 4084 GrantCommon Stock 1,318 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-040446 · doc4.xml · nonDerivative · entry 1

Stakias G. Michael · CIK 0001652688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,881

Read SEC document
July 01, 2017 Filed Jul 5, 2017 20:08 UTC Dorman Products, Inc. DORM · Entity 4084 GrantCommon Stock 1,088 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-043249 · doc4.xml · nonDerivative · entry 1

Stakias G. Michael · CIK 0001652688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,563

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.